Rock Steady- A mobile, gamified vestibular rehabilitation tool for olderadults with complaints of dizziness

项目摘要 这个SBIR应用程序的长期目标是开发和测试岩石稳定，一个软件应用程序，为老年人 成年人头晕该产品与NIDCD的使命相关，因为它满足了“ 发展研究、诊断和治疗平衡障碍的技术，特别是老年人的平衡障碍”。 设想的产品是一个优雅简单的移动的应用程序，旨在评估损伤，跟踪 症状，并测量对凝视稳定性家庭锻炼计划的依从性，该计划基于来自 2016前庭康复临床实践指南岩石稳定的构想是为了回应四个主要的 当前VRT医疗保健提供模式的局限性：1）访问，2）需要开发参与性运动 将提高对VRT的依从性的程序，3）性能差，以及4）缺乏远程监控能力。 鉴于老年人口不断增加，而且通过智能手机传播方便， 平板电脑/PC正在以前所未有的速度被老年人采用。将应用程序部署到通用数字 技术将确保其广泛采用。最后，它将根据所有利益相关者群体的反馈进行设计 包括前庭功能障碍的人第二阶段的目标是完成研究和开发 游戏化的凝视稳定性练习，并进行探索性的试点研究，以收集有关岩石稳定的能力， 解决标准VRT交付模型中的当前限制;并收集数据，为未来的设计提供信息 随机临床试验（RCT）。第一阶段进展：我们开发了Rock Steady原型并评估了其可靠性， 有效性和可用性，整合眼/头跟踪，从利益相关者（临床医生和患者）获得反馈， 确定并评估了Rock Steady的内容扩展。第二阶段目标。具体目标1：全面发展 基于第1阶段和具体目标2的结果，稳扎稳打：进行探索性试点研究，以收集以下数据： Rock Steady能够解决标准VRT交付模型中的当前限制;并收集数据， 为未来的随机临床试验（RCT）设计提供信息。研究设计：试点将是一个随机的预- 测试/测试后平行组试验;参与者将接受A）标准前庭康复（S-VRT）或B）数字 使用Rock Steady应用程序（D-VRT）进行前庭康复，在家使用4周。将收集结果： 和测试后的会话。结果：我们将使用半结构化访谈、可用性调查、功能结果和 游戏/传感器结果来评估Rock Steady。预期成果：我们相信，岩石稳定将提供 向患者和临床医生提供适当的反馈，提高依从性，可用，实现远程监测，并且可行 作为家庭锻炼计划的一部分，对患有头晕的成年人的功能产生积极影响。

Project Summary The long-term objective of this SBIR application is to develop and test Rock Steady, a software application for older adults with dizziness. This product is relevant to the mission of the NIDCD because it addresses the request for, “the development of technologies for the study, diagnosis, and treatment of balance disorders, particularly for the elderly”. The envisioned product is an elegantly simple mobile application that is designed to evaluate impairment, track symptoms, and measure adherence to gaze stability home exercise programs which are based on recommendations from the 2016 Clinical Practice Guidelines for Vestibular Rehabilitation. Rock Steady was conceived in response to four main limitations in the current VRT healthcare delivery model: 1) access, 2) the need for developing engaging exercise programs that will improve adherence to VRT, 3) poor performance, and 4) absence of remote monitoring capabilities. This application is very timely given the ever-enlarging older adult population and the ease of dissemination via smart tablets/PCs which are being adopted by older adults at faster rates than ever before. Deploying the app on common digital technology will ensure its widespread adoption. Finally, it will be designed with feedback from all stakeholder groups including people with vestibular dysfunction. The objective of Phase II is to complete the research and development of gamified gaze stability exercises and to conduct an exploratory pilot study to gather data about Rock Steady's ability to address current limitations in the standard VRT delivery model; and to gather data that will inform the design of a future randomized clinical trial (RCT). Phase I Progress: We developed the Rock Steady prototype and evaluated its reliability, validity and usability, integrated eye/head tracking, obtained feedback from stakeholders (clinicians and patients) and identified and evaluated content expansions for Rock Steady. Phase 2 Aims. Specific Aim 1: Complete development of Rock Steady based on results from Phase 1, and Specific Aim 2: Conduct an exploratory pilot study to gather data about Rock Steady's ability to address current limitations in the standard VRT delivery model; and to gather data that will inform the design of a future randomized clinical trial (RCT). Research Design: The pilot will be a randomized pre- test/post-test parallel group trial; participants will receive either A) standard vestibular rehabilitation (S-VRT) or B) digital vestibular rehabilitation using the Rock Steady app (D-VRT) to use at home for 4 weeks. Outcomes will be collected: pre- and post-test sessions. Outcomes: We will use semi-structured interviews, usability surveys, functional outcomes and game/sensor outcomes to evaluate Rock Steady. Expected Outcomes: We believe that Rock Steady will provide appropriate feedback to patients and clinicians, improve adherence, be usable, enable remote monitoring and be feasibly used as part of a home exercise program that positively impacts function in adults with dizziness.